Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Non Operating Income of $2.7 million in Q1 2026, up 12313.64% quarter-over-quarter from -$22000.0 in Q4 2025, and up 2019.29% on a YoY basis from $126788.0 in Q1 2025.
Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026) Analysis & Trends
Prothena Corp Public's Non Operating Income history runs 14 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 2019.29% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.5 million (down 78.97% YoY), while the FY2025 annual figure was -$328000.0, down 101.28% from the prior year.
- Non Operating Income was $2.7 million for Q1 2026 at Prothena Corp Public, up from -$22000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $7.1 million in Q1 2024 to a low of -$327000.0 in Q4 2022.
- Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of -$23000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income plunged 1357.69% in 2022, then surged 44613.33% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$327000.0 in 2022, then soared by 37.31% to -$205000.0 in 2023, then jumped by 2732.2% to $5.4 million in 2024, then plunged by 100.41% to -$22000.0 in 2025, then surged by 12313.64% to $2.7 million in 2026.
- The last three Non Operating Income figures came in at $2.7 million (Q1 2026), -$22000.0 (Q4 2025), and -$23000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -140,000.00 |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | -141,000.00 |
| Dec 31, 2022 | -327,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 690,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Sep 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -53,000.00 |